SCHEMBL29964392

SCHEMBL29964392

CC(C)(C)OC(=O)N1CCc2nc(Cl)ncc2C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.38
PIM1 P11309 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
POLB P06746 1/20 0.36
BUB1 O43683 1/20 0.35
ELANE P08246 1/20 0.35
STK17B O94768 1/20 0.34
STK17A Q9UEE5 1/20 0.34
PLK1 P53350 1/20 0.34
UCHL1 P09936 2/20 0.33
CKS1B P61024 1/20 0.33
SKP1 P63208 1/20 0.33
SKP2 Q13309 1/20 0.33
PARP1 P09874 1/20 0.33
TNKS2 Q9H2K2 1/20 0.33
PARP2 Q9UGN5 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30915330 0.88 STK17B (0.36) MAPTPIM1PIM2CCNA2CDK2
SCHEMBL30294180 0.83 CCNA2 (0.52) MAPTPIM1PIM2CCNA2CDK2
SCHEMBL15880484 0.83 CCNA2 (0.52) MAPTPIM1PIM2CCNA2CDK2
SCHEMBL3400140 0.81 PIM1 (0.40) MAPTPIM1PIM2POLBBUB1
SCHEMBL30684862 0.81 PIM1 (0.40) MAPTPIM1PIM2POLBBUB1
SCHEMBL12078079 0.78 ESR2 (0.40) MAPTPIM1PIM2POLBBUB1
SCHEMBL30549859 0.78 ESR2 (0.40) MAPTPIM1PIM2POLBBUB1
SCHEMBL31537609 0.78 BUB1 (0.38) MAPTPIM1PIM2POLBBUB1
SCHEMBL29237085 0.77 SMN1; SMN2 (0.40) MAPTPIM1PIM2POLBBUB1
SCHEMBL30969626 0.77 SMN1; SMN2 (0.40) MAPTPIM1PIM2POLBBUB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2024-10-17 US disclosed
WO-2022226668-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) ONTARIO INSTITUTE FOR CANCER RESEARCH (OICR) (CA) 2022-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240343704-A1 HALO-SUBSTITUTED AMINO PYRIDINE COMPOUNDS AS INHIBITORS OF THE HAEMATOPOIETIC PROGENITOR KINASE 1 (HPK1) CMPK1, WNK1, AAK1 MAPT 3643/4885PIM1 312/4885PIM2 519/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.